TCT-43. Final Five-year Follow-up of the SYNTAX Trial: Optimal Revascularization Strategy in Patients with Three-vessel Disease

Presenter: A. Pieter Kappetein

REGISTER for free or LOG IN to view this content

TCT-43. Final Five-year Follow-up of the SYNTAX Trial: Optimal Revascularization Strategy in Patients with Three-vessel Disease

We Recommend